|Bid||0.00 x 38700|
|Ask||0.00 x 105300|
|Day's Range||80.44 - 81.74|
|52 Week Range||76.42 - 93.82|
|PE Ratio (TTM)||19.50|
|Earnings Date||May 3, 2018|
|Forward Dividend & Yield||1.06 (1.28%)|
|1y Target Est||92.98|
Wide range of dialysis products, deliberate initiatives to gain market traction and solid international foothold are major catalysts for Fresenius Medical (FMS) at the moment.
Fresenius Medical Care AG & Co KGaA (XTRA:FME) is trading with a trailing P/E of 19.6x, which is lower than the industry average of 21x. Although some investors may jumpRead More...
Here we analyze how the U.S. MedTech space is gearing up to counter the disquieting CBO projections regarding federal deficit.
Higher sales of dialyzers, machines, peritoneal dialysis products, renal pharmaceuticals, bloodlines and products for acute care boost Fresenius Medical (FMS) in Q4.
BAD HOMBURG, GERMANY / ACCESSWIRE / February 27, 2018 / Fresenius Medical Care, the world's largest provider of dialysis products and services, announced that it has filed the annual report 2017 under ...
Fresenius Medical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.
Haemonetics Corporation (NYSE: HAE ), a provider of blood and plasma services and supplies, may be benefiting from improved visibility on its transformation, according to Morgan Stanley. Raymond James ...
Fresenius Medical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
Categories: Yahoo FinanceGet free summary analysis Fresenius Medical Care AG & Co. KGaA reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Fresenius Medical Care AG & Co. KGaA – Fresenius SE & Co. KGaA, Baxter International Inc. and MEDICLIN AG (FRE-DE, BAX-CH and MED-DE) that ... Read more (Read more...)
Fresenius Medical Care North America employees put on their walking shoes and raised nearly $300,000, the most amount ever raised by a National Team participating in Kidney Walk, the centerpiece fundraiser of the National Kidney Foundation .
Fresenius Medical Care North America , the country’s leading provider of kidney care products and services, announced today the first performance year results from its End Stage Renal Disease Seamless Care Organizations .
RICHMOND, Va. , Nov. 20, 2017 /PRNewswire/ -- Capital Square 1031 announced today that its Delaware statutory trust offerings, CS1031 Morganton MOB, DST and CS1031 Louisburg MOB, DST, each comprised of ...
Categories: Europe Stock Alerts Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Fresenius Medical Care AG & Co. KGaA. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 ... Read more (Read more...)
Fresenius Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
Strong growth in Health Care Products and Health Care Services segments drove Fresenius's (FMS) third-quarter revenues. Lackluster performance by the renal pharmaceutical segment is a concern.
The Bad Homburg, Germany-based company said it had profit of 59 cents per share. The dialysis services provider posted revenue of $5.09 billion in the period. Fresenius shares have climbed 15 percent since ...